The National Society of Medical Directors in Italy have identified the hydrogen peroxide mist system as “significantly important” in new guidelines into automated area decontamination following outstanding results from field trials in reducing infection.
New guidelines into the use of automated area decontamination in hospitals have identified ASP’s GLOSAIR™ technology as a “preventative” and “totally eradicating” action against healthcare associated infections.
With AAD becoming widely recognised as a method to fight infections, the National Society of Medical Directors (ANMDO), based in Italy, took the lead in preparing guidelines for using the technologies. They reviewed the GLOSAIR™ system by reading existing studies and carrying out their own field trials.
The research has led ANMDO to recommend the use of AAD for HAI prevention and outbreak control.
Trials were carried out in Polyclinic Vittorio Emanuele Hospital in Catania and the Salus Clinical Institute in Alessandria. Results showed that all the samples from the surfaces demonstrated the absence or at least reduced load of pathogens (bacteria and fungi) after treatment with the AAD system. In no case was the presence of any pathogen found.
Based on this, ANMDO published a national recommendation for Italy and stated in their guidelines that a hydrogen peroxide mist system such as GLOSAIR™ was significantly important as:
Furthermore the technology was found to be simple to use for junior healthcare staff, would only have a minor influence on care-giving activities and was innocuous for operators because it was neither toxic nor carcinogenic.
In summary the authors1 said: “The efficacy of the technology is able to offer a standardized, reproducible decontamination procedure with the same characteristics in every situation in which its use could be beneficial.
“It helps to reduce human error, which is often detected on the part of the operators in the usual cleaning procedures and reducing management costs related to the action that needs to be taken in the event of contamination of patients, operators and hospital areas.”
1 Dr. Gianfranco Finzi, Prof. Ugo Luigi Aparo , Dr. Rosario Cunsolo , Dr. Clemente Ponzetti , Dr. Barbara Gozzi , Eng. Silvia Cugini
This link will take you to a Web site to which this Privacy Policy does not apply.
We encourage you to read the Privacy Policy of every Web site you visit.